Company / Working Capital per Share
NeoGenomics Laboratories, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.25
FY2025
5-year range
$2.25 / $4.95
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
#115 of 158
Health Care
What the data says
At $2.25, NeoGenomics Laboratories, Inc.'s working capital per share ranks #115 of 158 in the Health Care sector. Working Capital per Share has declined for 4 consecutive years, from $4.95 in FY2021 to $2.25 in FY2025.
Based on SEC 10-K filings.
2.25 in FY2025 with a 5-year CAGR of -7.7%.
Declined from $3.99 to $2.25 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -18.5%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
#115 of 158 in Health CareTop 73% of 158This company $2.25 Sector average $24.45
▼
-90.8% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 3.4% year-over-year.
- Ranks #115 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.25 | -3.4% |
| FY2024 | $2.33 | -41.6% |
| FY2023 | $3.99 | -3.9% |
| FY2022 | $4.15 | -16.3% |
| FY2021 | $4.95 | +47.5% |
| FY2020 | $3.36 | +53.4% |
| FY2019 | $2.19 | +369.0% |
| FY2018 | $0.47 | -25.8% |
| FY2017 | $0.63 | +17.1% |
| FY2016 | $0.54 | -23.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026